Business

Health Canada suspends licenses for Evergreen

The Federal regulatory authorities suspended the license of Canadian-based cannabis grower Evergreen Medicinal Supply Inc. (British Columbia) to grow and sell cannabis. The agency did so in order to protect public health and safety. According to Health Canada, the principles and options in the Canadian marijuana market were not fully followed by the Evergreen company.

Investors await Health Canada’s ruling on how it will enforce CannTrust’s compliance breaches. Meanwhile, the federal agency suspended the Evergreen marijuana producer’s license due to “critical observations”.

Health Canada Suspends B.C. Pot Firm Evergreen’s Licences

Health Canada spokeswoman Tammy Jarbeau confirmed in an email that a government agency suspended Evergreen’s ability to “grow, process and sell dried and fresh cannabis, cannabis plants and cannabis seeds.” It happened in August after an unannounced inspection that led to the imposition of non-compliance with the company.

“On August 9, Health Canada suspended licenses for Evergreen Medicinal Supply to protect public health and safety. This included the prevention of sending cannabis to the illegal market for non-compliance with certain provisions of the Cannabis Act and the Cannabis Regulations,” as Health Canada spokesperson wrote in an email statement.

Health Canada received a license to sell cannabis from Winnipeg marijuana producer

The suspension of Evergreen Medicinal is the second case in which Health Canada imposed such a measure on a recognized cannabis manufacturer. Earlier this year, Health Canada received a license to sell cannabis from Winnipeg marijuana producer. The authorities suspended Bonify Holdings Corp. license after it was found that the company was selling cannabis from illegal sources.

Health Canada suspended Evergreen’s licenses to produce and sell marijuana. (Source)

In addition, investors are currently awaiting the Health Canada verdict on the penalty it will impose on CannTrust Holdings. Moreover, this regulator discovered that thousands of kilograms of cannabis are grown in unlicensed and unauthorized rooms. Possible penalties for CannTrust range from a $1 fine to suspension or withdrawal of the company’s ability to produce and sell legal cannabis in Canada.

The Health Canada clampdown

Jarbeau from Health Canada said that Evergreen reacted already to the license suspension on September 9. And, moreover, was “working on corrective measures,” which will be further assessed by regulators.

Jarbeau said that Health Canada inspectors conducted an unannounced inspection at the company’s facility in Saanichton, BC in April. He added that the inspection revealed, “a series of critical observations and overall non-conforming assessments” regarding the company’s manufacturing practices. In addition, they found problems with data storage, inventory management and compliance with licensing controls.

Evergreen received a license to sell medical marijuana in March 2017. Besides, it operated primarily to produce legal weeds for other licensed producers. According to 2017’s press release, Evergreen operates a 5,700 square foot plant in Saanichton. It is approximately 20 kilometers north of Victoria. Furthermore, the company received zone permits to extend the production area to an additional 150,000 square feet.

The suspension of Evergreen Medicinal is the second case in which Health Canada imposed such a measure on a recognized cannabis manufacturer. (Source)

Evergreen suffers a recent unpaid rent and expired the lease

Documents from the British court also show that Evergreen suffered a recent unpaid rent. Philip Illingworth, the owner of the land on which Evergreen operated, said the company owed him $425,061 in rent and is still operating. Even though the lease expired at the end of last year.

Judge BD MacKenzie decided in favor of Illingworth in July and ordered Evergreen to leave his facility at the end of August, in accordance with CanLII’s court documents. Shawn Galbraith, founder, and CEO of Evergreen did not respond immediately to many requests for comments.

(Featured Image by Activedia)

First published in drugsinc, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Eva Wesley

Eva Wesley is an experienced journalist, market trader, and financial executive. Driven by excellence and a passion to connect with people, she takes pride in writing think pieces that help people decide what to do with their investments. A blockchain enthusiast, she also engages in cryptocurrency trading. Her latest travels have also opened her eyes to other exciting markets, such as aerospace, cannabis, healthcare, and telcos.

Recent Posts

Berlin Will Launch Pilot Project for Legal Cannabis Sales

Berlin is launching a pilot project in the Friedrichshain-Kreuzberg and Neukölln districts to study the…

1 week ago

Legalizace, Czech Cannabis Magazine, Accused of “Promoting Drug Addiction”, Wins Case

The Czech Constitutional Court overturned a previous ruling accusing Robert Veverka, former editor of Legalizace,…

2 weeks ago

U.N. High Commissioner for Human Rights Declares the War on Drugs a Failure

U.N. High Commissioner for Human Rights Volker Türk has declared the war on drugs a…

2 weeks ago

Pennsylvania Lawmakers Unveil New Plan to Legalize Cannabis

Pennsylvania lawmakers have proposed a plan to legalize recreational cannabis by 2025. Projections estimate up…

2 weeks ago

United States — First Step in DEA Hearing on Cannabis Reclassification

The DEA just held its first procedural hearing on cannabis reclassification, although the focus was…

3 weeks ago

Brazil — Supreme Court Legalizes the Cultivation, Processing, and Sale of Hemp for Medical Purposes

The Superior Court of Justice in Brazil has legalized the cultivation, processing, and sale of…

3 weeks ago